These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14987586)

  • 1. NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.
    Hartmann F; Packer M; Coats AJ; Fowler MB; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Trawinski J; Amann-Zalan I; Hoersch S; Katus HA
    Eur J Heart Fail; 2004 Mar; 6(3):343-50. PubMed ID: 14987586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
    Hartmann F; Packer M; Coats AJ; Fowler MB; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Anker SD; Amann-Zalan I; Hoersch S; Katus HA
    Circulation; 2004 Sep; 110(13):1780-6. PubMed ID: 15381643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
    Olsson LG; Swedberg K; Cleland JG; Spark PA; Komajda M; Metra M; Torp-Pedersen C; Remme WJ; Scherhag A; Poole-Wilson P;
    Eur J Heart Fail; 2007 Aug; 9(8):795-801. PubMed ID: 17693380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?
    Gardner RS; Henderson G; McDonagh TA
    J Heart Lung Transplant; 2005 Mar; 24(3):303-9. PubMed ID: 15737757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
    Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure.
    Gundogdu F; Bozkurt E; Kiziltunc A; Sevimli S; Arslan S; Gurlertop Y; Senocak H; Karakelleoglu S
    Echocardiography; 2007 Feb; 24(2):113-7. PubMed ID: 17313541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study.
    Cleland JG; Taylor J; Freemantle N; Goode KM; Rigby AS; Tendera M
    Eur J Heart Fail; 2012 May; 14(5):487-94. PubMed ID: 22505395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
    Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.